Obstetrics & Gynecology

Skip Navigation LinksHome > June 2014 - Volume 123 - Issue 6 > Improving Care for Depression in Obstetrics and Gynecology:...
Obstetrics & Gynecology:
doi: 10.1097/AOG.0000000000000231
Contents: Original Research

Improving Care for Depression in Obstetrics and Gynecology: A Randomized Controlled Trial

Melville, Jennifer L. MD, MPH; Reed, Susan D. MD, MPH; Russo, Joan PhD; Croicu, Carmen A. MD; Ludman, Evette PhD; LaRocco-Cockburn, Anna MSW, MPH; Katon, Wayne MD

Journal Club
Cochrane Reviews
Clinical ObGyn
Annual Awards
Collapse Box

Abstract

OBJECTIVE: To evaluate an evidence-based collaborative depression care intervention adapted to obstetrics and gynecology clinics compared with usual care.

METHODS: A two-site, randomized controlled trial included screen-positive women (Patient Health Questionnaire-9 score of at least 10) who met criteria for major depression, dysthymia, or both (Mini-International Neuropsychiatric Interview). Women were randomized to 12 months of collaborative depression management or usual care; 6-month, 12-month, and 18-month outcomes were compared. The primary outcomes were change from baseline to 12 months in depression symptoms and functional status. Secondary outcomes included at least 50% decrease and remission in depressive symptoms, global improvement, treatment satisfaction, and quality of care.

RESULTS: Participants were, on average, 39 years old, 44% were nonwhite, and 56% had posttraumatic stress disorder. Intervention (n=102) compared with usual care (n=103) patients had greater improvement in depressive symptoms at 12 months (P<.001) and 18 months (P=.004). The intervention group compared with usual care group had improved functioning over the course of 18 months (P<.05), were more likely to have at least 50% decrease in depressive symptoms at 12 months (relative risk [RR] 1.74, 95% confidence interval [CI] 1.11–2.73), greater likelihood of at least four specialty mental health visits (6-month RR 2.70, 95% CI 1.73–4.20; 12-month RR 2.53, 95% CI 1.63–3.94), adequate dose of antidepressant (6-month RR 1.64, 95% CI 1.03–2.60; 12-month RR 1.71, 95% CI 1.08–2.73), and greater satisfaction with care (6-month RR 1.70, 95% CI 1.19–2.44; 12-month RR 2.26, 95% CI 1.52–3.36).

CONCLUSION: Collaborative depression care adapted to women's health settings improved depressive and functional outcomes and quality of depression care.

CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT01096316.

LEVEL OF EVIDENCE: I

© 2014 by The American College of Obstetricians and Gynecologists.

Login

 

Looking for ABOG articles? Visit our ABOG MOC II collection. The selected Green Journal articles are free through the end of the calendar year.

ACOG MEMBER SUBSCRIPTION ACCESS

If you are an ACOG Fellow and have not logged in or registered to Obstetrics & Gynecology, please follow these step-by-step instructions to access journal content with your member subscription.

Article Tools

Share

Article Level Metrics